Posted on

Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Our anti-infective treatments are generics that combat serious bacterial and antibiotic resistant infections as well as certain fungal diseases. Xellia is wholly owned by Novo A/S since 2013 and headquartered in Copenhagen, Denmark. The Bedford, Ohio location is a production site.